Lessons From Large Clinical Trials in Managing COPD Patients
PDF
Cite
Share
Request
Review
VOLUME: 10 ISSUE: 3
P: 130 - 139
September 2009

Lessons From Large Clinical Trials in Managing COPD Patients

Turk Thorac J 2009;10(3):130-139
1. Fundació Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain
2. The University of Texas Health Science Center, Department of Pulmonary/Critical Care, Texas, USA
No information available.
No information available
Accepted Date: 18.07.2019
Online Date: 18.07.2019
Publish Date: 18.07.2019
PDF
Cite
Share
Request

Abstract

Abstract

Large, multicenter, randomized controlled trials in COPD have recently been completed. The largest of these studies are “Towards a Revolution in COPD Health” (TORCH) and “Understanding Potential Long-Term Impacts on Function with Tiotropium” (UPLIFT®). These studies make considerable contributions to understanding the natural history of COPD. The objective of this article is to review the data from these different trials in order to find what can be learnt of the management of COPD. The long-term improvements in lung function, health-related quality of life, and possibly survival from the use of long-acting bronchodilators in these trials suggest an influence on the progression of the disease.

Keywords:
Bronchodilators, lung function, FEV1, fluticasone, inhaled corticosteroids, long-acting beta agonists, long-acting anticholinergics, mortality, salmeterol, tiotropium